(Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for ...
Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent ...
In heart failure, the heart can no longer supply the body with enough blood. The condition often develops over many years, ...
Targeting organ‑specific gene “switches” can reverse key markers of liver aging in mice, suggesting aging might be slowed one ...
Morning Overview on MSN
Metabolic enzyme may predict who benefits from cancer immunotherapy
A metabolic enzyme found in the support cells surrounding tumors may hold the key to predicting which cancer patients will ...
Researchers at the Department of Pharmacology and Toxicology at the University Medical Center Göttingen (UMG) have discovered a key genetic regulatory mechanism that becomes disrupted in heart failure ...
We each shed millions of skin cells every day. A wealth of different types of cells lurk beyond the epidermis, the outer ...
Postdoctoral training is a defining stage in a scientist’s career, offering the mentored research experience and professional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results